StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$1.96+0.07 (+3.70%)

Close on Nov 17, 2026Market cap $18.90MP/E –Yield –

Edesa Biotech total assets

Total assets on the balance sheet at the end of each period.

Edesa Biotech's total assets was $12.72M at Jun 30, 2026. For fiscal 2025 it was $13.53M, up 254.8% from the year before. Over ten years it grew -0.7% a year on average. The highest annual figure on record is $14.58M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Sep 30, 2025$13.53M+254.8%
FY2024Sep 30, 2024$3.81M-57.1%
FY2023Sep 30, 2023$8.89M-23.2%
FY2022Sep 30, 2022$11.58M-20.6%
FY2021Sep 30, 2021$14.58M+35.5%
FY2020Sep 30, 2020$10.76M+88.2%
FY2019Sep 30, 2019$5.72M-51.5%
FY2018Sep 30, 2018$11.78M+52.6%
FY2017Sep 30, 2017$7.72M-40.3%
FY2016Sep 30, 2016$12.94M-10.6%
FY2014Aug 31, 2014$14.47M+70.0%
FY2013Aug 31, 2013$8.51M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$12.72M-14.1%
Q2 FY2026CQ1 2026Mar 31, 2026$12.38M-24.7%
Q1 FY2026CQ4 2025Dec 31, 2025$14.71M+253.3%
Q4 FY2025CQ3 2025Sep 30, 2025$13.53M+254.8%
Q3 FY2025CQ2 2025Jun 30, 2025$14.80M+183.2%
Q2 FY2025CQ1 2025Mar 31, 2025$16.45M+154.1%
Q1 FY2025CQ4 2024Dec 31, 2024$4.16M-46.8%
Q4 FY2024CQ3 2024Sep 30, 2024$3.81M-57.1%
Q3 FY2024CQ2 2024Jun 30, 2024$5.23M-44.5%
Q2 FY2024CQ1 2024Mar 31, 2024$6.48M-39.3%
Q1 FY2024CQ4 2023Dec 31, 2023$7.83M-32.9%
Q4 FY2023CQ3 2023Sep 30, 2023$8.89M-23.2%
Q3 FY2023CQ2 2023Jun 30, 2023$9.42M-46.3%
Q2 FY2023CQ1 2023Mar 31, 2023$10.67M-47.7%
Q1 FY2023CQ4 2022Dec 31, 2022$11.67M-5.4%
Q4 FY2022CQ3 2022Sep 30, 2022$11.58M-20.6%
Q3 FY2022CQ2 2022Jun 30, 2022$17.54M+3.9%
Q2 FY2022CQ1 2022Mar 31, 2022$20.41M-15.0%
Q1 FY2022CQ4 2021Dec 31, 2021$12.34M+19.9%
Q4 FY2021CQ3 2021Sep 30, 2021$14.58M+35.5%
Q3 FY2021CQ2 2021Jun 30, 2021$16.88M+89.1%
Q2 FY2021CQ1 2021Mar 31, 2021$24.00M+214.5%
Q1 FY2021CQ4 2020Dec 31, 2020$10.29M+102.2%
Q4 FY2020CQ3 2020Sep 30, 2020$10.76M+88.2%
Q3 FY2020CQ2 2020Jun 30, 2020$8.92M+23.5%
Q2 FY2020CQ1 2020Mar 31, 2020$7.63M-16.6%
Q1 FY2020CQ4 2019Dec 31, 2019$5.09M+49.8%
Q4 FY2019CQ3 2019Sep 30, 2019$5.72M-51.5%
Q3 FY2019CQ2 2019Jun 30, 2019$7.23M-43.5%
Q2 FY2019CQ1 2019Mar 31, 2019$9.15M+71.7%
Q1 FY2019CQ4 2018Dec 31, 2018$3.40M-48.5%
Q4 FY2018CQ3 2018Sep 30, 2018$11.78M+52.6%
Q3 FY2018CQ2 2018Jun 30, 2018$12.80M+41.9%
Q2 FY2018CQ1 2018Mar 31, 2018$5.33M-47.9%
Q1 FY2018CQ4 2017Dec 31, 2017$6.59M-42.5%
Q4 FY2017CQ3 2017Sep 30, 2017$7.72M-40.3%
Q3 FY2017CQ2 2017Jun 30, 2017$9.02M–
Q2 FY2017CQ1 2017Mar 31, 2017$10.22M–
Q1 FY2017CQ4 2016Dec 31, 2016$11.47M–
Q4 FY2016CQ3 2016Sep 30, 2016$12.94M–

More Edesa Biotech figures

See a number that looks wrong?